{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:43:02Z","timestamp":1762980182781},"reference-count":30,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T00:00:00Z","timestamp":1464825600000},"content-version":"vor","delay-in-days":367,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.jacc.2015.03.564","type":"journal-article","created":{"date-parts":[[2015,5,25]],"date-time":"2015-05-25T18:15:24Z","timestamp":1432577724000},"page":"2337-2344","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Strategies to Incorporate Left Atrial Appendage Occlusion Into Clinical Practice"],"prefix":"10.1016","volume":"65","author":[{"given":"Oluseun","family":"Alli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Asirvatham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"David R.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2015.03.564_bib1","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2015.03.564_bib2","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","article-title":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials","volume":"154","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2015.03.564_bib3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","article-title":"Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis","volume":"131","author":"Hart","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2015.03.564_bib4","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2015.03.564_bib5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/CIRCULATIONAHA.110.976449","article-title":"Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry","volume":"123","author":"Reddy","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.03.564_bib6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jacc.2012.06.046","article-title":"Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience","volume":"62","author":"Bartus","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.03.564_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure Device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.03.564_bib8","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.112.114389","article-title":"Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) trial","volume":"127","author":"Reddy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.03.564_bib9","unstructured":"Boston Scientific. Boston Scientific Receives FDA Approval For WATCHMAN Left Atrial Appendage Closure Device. March 13, 2015. Available at: http:\/\/www.multivu.com\/players\/English\/7223452-boston-scientific-watchman-fda-approval\/. Accessed April 1,\u00a02015."},{"key":"10.1016\/j.jacc.2015.03.564_bib10","unstructured":"Boston Scientific. WATCHMAN Left Atrial Appendage Closure Device With Delivery System. 2014. Available at: http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf13\/P130013d.pdf. Accessed April 1,\u00a02015."},{"key":"10.1016\/j.jacc.2015.03.564_bib11","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(98)01401-9","article-title":"Prevalence of atrial fibrillation and eligibility for anticoagulants in the community","volume":"352","author":"Sudlow","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2015.03.564_bib12","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1161\/01.STR.28.12.2382","article-title":"Warfarin use among patients with atrial fibrillation","volume":"28","author":"Brass","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2015.03.564_bib13","doi-asserted-by":"crossref","first-page":"927","DOI":"10.7326\/0003-4819-131-12-199912210-00004","article-title":"Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study","volume":"131","author":"Go","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2015.03.564_bib14","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4244\/EIJV6I2A35","article-title":"PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study","volume":"6","author":"Bayard","year":"2010","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2015.03.564_bib15","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.jacc.2013.03.035","article-title":"Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology)","volume":"61","author":"Reddy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.03.564_bib16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","volume":"57","author":"Lip","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.03.564_bib17","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/europace\/eur126","article-title":"Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis","volume":"13","author":"Lip","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2015.03.564_bib18","doi-asserted-by":"crossref","first-page":"e002212","DOI":"10.1161\/JAHA.112.002212","article-title":"Ablation for atrial fibrillation in combination with left atrial appendage closure: first results of a feasibility study","volume":"1","author":"Swaans","year":"2012","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2015.03.564_bib19","first-page":"E32","article-title":"Two in a single procedure: combined approach for MitraClip implantation and left atrial appendage occlusion using the Watchman device","volume":"26","author":"Schade","year":"2014","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.jacc.2015.03.564_bib20","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/europace\/eus305","article-title":"2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation\u2014developed with the special contribution of the European Heart Rhythm Association","volume":"14","author":"Camm","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2015.03.564_bib21","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/europace\/euu174","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion","volume":"16","author":"Meier","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2015.03.564_bib22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/ccd.10660","article-title":"Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation","volume":"60","author":"Meier","year":"2003","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2015.03.564_bib23","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/ccd.22764","article-title":"Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience","volume":"77","author":"Park","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2015.03.564_bib24","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/ccd.23136","article-title":"Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience","volume":"79","author":"Lam","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2015.03.564_bib25","article-title":"Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug","author":"Tzikas","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2015.03.564_bib26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.hrthm.2013.11.030","article-title":"Left atrial appendage closure: a new technique for clinical practice","volume":"11","author":"Camm","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2015.03.564_bib27","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.hrthm.2014.01.019","article-title":"The effects of LAA ligation on LAA electrical activity","volume":"11","author":"Han","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2015.03.564_bib28","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jacc.2014.03.057","article-title":"Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. Transcatheter LAA Ligation Consortium","volume":"64","author":"Price","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.03.564_bib29","first-page":"45","article-title":"Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III","volume":"3","author":"Whitlock","year":"2014","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.jacc.2015.03.564_bib30","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jacc.2012.09.001","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document","volume":"60","author":"Kappetein","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109715017799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109715017799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T04:11:00Z","timestamp":1652069460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109715017799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":30,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0735109715017799"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2015.03.564","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategies to Incorporate Left Atrial Appendage Occlusion Into Clinical Practice","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2015.03.564","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}